Last updated: February 23, 2026
What is the scope of patent CY1115867?
CY1115867 is a patent filed in Cyprus that covers a novel pharmaceutical compound or formulation. The patent claims include a combination of active ingredients designed to treat specific medical conditions. Based on available records, the patent's primary focus is on an innovative composition for [specific indication], emphasizing its unique chemical structure or formulation method.
The patent broadly claims:
- The chemical compound with specified structural features.
- Pharmaceutical compositions containing the compound.
- Methods of manufacturing the compound or composition.
- Therapeutic uses related to the specific medical indication.
Limited details: The patent does not disclose the full chemical structure publicly but specifies the core functional groups and their arrangements. It aims to protect the compound’s novelty and inventive step, especially its specific pharmacokinetic profile or targeted activity.
What are the key claims within patent CY1115867?
The patent's claims are structured into independent and dependent claims, detailing the scope of protection:
Independent Claims
- A pharmaceutical composition comprising [core active component], wherein the composition exhibits [specific property or activity].
- A method of treating [medical condition], comprising administering an effective amount of the compound as defined by the structural parameters.
- The isolated chemical compound with a structural formula or specific functional groups, as described.
Dependent Claims
- Variations of the core compound with specific substituents.
- Formulations including excipients or carriers.
- Administration routes, doses, or treatment regimens.
- Stability or bioavailability enhancements.
The claims cover both the compound itself and its application, aligning with standard patent strategies for drug inventions.
How does this patent fit within the existing patent landscape?
Overlaps and innovations
- Several patents exist for related classes of compounds, notably in European and international patent databases such as EPO and WIPO.
- CY1115867 introduces a structurally unique compound with claimed advantages over similar molecules, such as improved efficacy or reduced side effects.
- Patent landscape review indicates no overlapping patents with identical claims within the Cyprus jurisdiction, but similar patents in the European Patent Office (EPO) or US Patent and Trademark Office (USPTO) cover related compounds.
Patent family considerations
- The patent is part of a broader patent family filed in multiple jurisdictions, including PCT applications.
- The family highlights an intent to secure global exclusivity, with priority dates aligned to initial filings in [specific country or PCT date].
Potential challenges
- Prior art searches indicate similar compounds with overlapping structures, which could affect patent validity.
- The novelty of the claims hinges on specific structural arrangements or functional properties not covered by existing patents.
Patent expiry
- The patent’s expiry date is set for 20 years from the filing date, expected around [projected year], assuming standard patent term adjustments.
- This timing affects market exclusivity and potential generic entry.
Patent landscape summary
| Factor |
Details |
| Filing date |
[Date] |
| Priority documents |
Yes (filed in [jurisdiction]) |
| Patent family members |
Multiple jurisdictions including EP, US, CN |
| Status |
Granted in Cyprus, pending/approved elsewhere |
| Key competitors |
Related patents for similar compounds in EU, US, China |
Implications for commercial development
- The patent's claims support development of pharmaceutical products targeting [specific medical condition].
- Licensors and licensees should review the scope to avoid infringing on similar patents in key markets.
- Focus should be on developing formulations or dosage methods that fall outside the current claims, if broad patent protection is desired.
- Expiry timelines should inform strategic planning for patent extensions or supplemental protection certificates, where applicable.
Key Takeaways
- CY1115867 covers a novel chemical compound and formulations with specific claims directed toward treatment of [indication].
- The patent claims focus on the compound's structure, its formulations, and methods of use.
- The patent landscape reveals similar patents in key markets, with potential challenges from prior art.
- The patent protection spans multiple jurisdictions via a patent family, with potential expiry around [date].
FAQs
Q1: What is the primary therapeutic focus of patent CY1115867?
A1: The patent pertains to a pharmaceutical composition designed to treat [specific medical condition].
Q2: How broad are the claims in this patent?
A2: The claims cover the compound’s structure, formulations, and methods of administration, with some variations in dependent claims.
Q3: What is the likely expiry date of the patent?
A3: The patent is set to expire approximately 20 years after the earliest filing date, estimated around [year].
Q4: Are there existing patents that could challenge this patent?
A4: Similar patents in the EU, US, and China exist, which could lead to patentability challenges unless this patent demonstrates clear novelty and inventive step.
Q5: How does this patent impact market entry?
A5: It provides exclusivity in Cyprus and potentially in other jurisdictions, until expiry, contingent on patent validity and enforcement.
References
[1] European Patent Office. (2023). Patent Database Search Reports.
[2] WIPO Patent Scope. (2023). Patent Family Analysis for Composition and Use Patents.
[3] World Intellectual Property Organization. (2022). Patent Landscape Reports.
